A double-blind, randomised, two arm parallel group trial to determine the effects of torasemide versus furosemide on one marker (PIP) of cardiac fibrosis in patient with HFpEF and T2DM
1 May 2017 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Charite University Hospital, Berlin (Germany)
84 More presentations in this session
Access the full session
The Event
Heart Failure 2017 - 4th World Congress on Acute Heart Failure
1 May 2017
08:30 CET
